Enhanced Human Epidermal Growth Factor Receptor 2 Degradation in Breast Cancer Cells by Lysosome-Targeting Gold Nanoconstructs

ACS Nano
Hyojin LeeTeri W Odom

Abstract

This paper describes how gold nanoparticle nanoconstructs can enhance anticancer effects of lysosomal targeting aptamers in breast cancer cells. Nanoconstructs consisting of anti-HER2 aptamer (human epidermal growth factor receptor 2, HApt) densely grafted on gold nanostars (AuNS) first targeted HER2 and then were internalized via HER2-mediated endocytosis. As incubation time increased, the nanoconstruct complexes were found in vesicular structures, starting from early endosomes to lysosomes as visualized by confocal fluorescence and differential interference contrast microscopy. Within the target organelle, lysosomes, HER2 was degraded by enzymes at low pH, which resulted in apoptosis. At specific time points related to the doubling time of the cancer cells, we found that accumulation of HER2-HApt-AuNS complexes in lysosomes, lysosomal activity, and lysosomal degradation of HER2 were positively correlated. Increased HER2 degradation by HApt-AuNS triggered cell death and cell cycle arrest in the G0/G1 phase inhibition of cell proliferation. This work shows how a perceived disadvantage of nanoparticle-based therapeutics-the inability of nanoconstructs to escape from vesicles and thus induce a biological response-can be overcome ...Continue Reading

References

Dec 22, 1999·The Journal of Clinical Investigation·G I Shapiro, J W Harper
Mar 4, 2000·Advanced Drug Delivery Reviews·R WattiauxM Jadot
May 20, 2000·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·T G Hønsi, J Stenersen
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·V P TorchilinT S Levchenko
Aug 28, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S MénardE Tagliabue
Aug 3, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jayanth PanyamVinod Labhasetwar
Sep 3, 2002·Advanced Drug Delivery Reviews·Irène BriggerPatrick Couvreur
Jun 20, 2003·Cell Proliferation·Katrien VermeulenZwi N Berneman
Jan 26, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M TannerJ Isola
Apr 14, 2005·Molecular Cancer Therapeutics·Danica RamljakRobert B Dickson
Oct 22, 2005·Nature Reviews. Cancer·Guido Kroemer, Marja Jäättelä
Mar 14, 2007·Autophagy·Olga ZabirnykOleksandr Seleverstov
Mar 31, 2007·Nature Reviews. Drug Discovery·David C RubinszteinDaniel J Klionsky
Jul 31, 2007·Advanced Drug Delivery Reviews·Lisa M Bareford, Peter W Swaan
Jun 17, 2008·Advanced Drug Delivery Reviews·Partha GhoshVincent M Rotello
Jul 26, 2008·Nature Nanotechnology·Wen JiangWarren C W Chan
Oct 9, 2008·Advanced Drug Delivery Reviews·James D ByrneLisa Brannon-Peppas
Oct 29, 2008·Oncogene·P Boya, G Kroemer
Oct 22, 2009·Small·Ayush Verma, Francesco Stellacci
Dec 5, 2009·The Journal of Biological Chemistry·Abedelnasser AbulrobLinda J Johnston
Jul 10, 2010·Nature Reviews. Drug Discovery·Robby A Petros, Joseph M DeSimone
Aug 10, 2010·Advanced Drug Delivery Reviews·Jin XieXiaoyuan Chen
Aug 12, 2010·Journal of the American Chemical Society·Jin WangJoseph M Desimone
Dec 1, 2010·Methods in Molecular Biology·Barry W Neun, Stephan T Stern
Sep 6, 2011·Annual Review of Medicine·Andrew Z WangOmid C Farokhzad
Nov 8, 2011·Nature Nanotechnology·Jong Ah KimKenneth A Dawson
Nov 24, 2011·Nano Reviews·Panikkanvalappil R SajanlalThalappil Pradeep
Dec 2, 2011·Chemical Society Reviews·Lev Dykman, Nikolai Khlebtsov
Mar 6, 2012·Chemical Society Reviews·Irene Canton, Giuseppe Battaglia
Mar 20, 2012·ACS Nano·Duncan Hieu M DamTeri W Odom
Jun 13, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Drew R EliasAndrew Tsourkas
May 1, 2013·Proceedings of the National Academy of Sciences of the United States of America·Georg MahlknechtYosef Yarden
Dec 3, 2014·Nanomedicine : Nanotechnology, Biology, and Medicine·Duncan Hieu M DamTeri W Odom

❮ Previous
Next ❯

Citations

May 28, 2016·Journal of Nanobiotechnology·Ewelina PiktelRobert Bucki
Feb 13, 2016·Chembiochem : a European Journal of Chemical Biology·Chun-Chi WangHuan-Tsung Chang
Jan 26, 2017·Journal of the American Chemical Society·Liqin ZhangWeihong Tan
Aug 26, 2017·International Journal of Molecular Sciences·Xiaoqiu WuGe Zhang
Mar 2, 2018·Lasers in Medical Science·Hasan NorouziFatemeh Akbarzadeh
Feb 11, 2020·Biomaterials Science·Andrea C Del ValleYu-Fen Huang
Sep 28, 2018·Advanced Materials·Wei-Hai ChenXian-Zheng Zhang
Aug 23, 2019·Technology in Cancer Research & Treatment·Bárbara Lara-ChacónMónica Raquel Calera
Mar 14, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Si ChenXianzheng Zhang
Jul 2, 2019·International Journal of Pharmaceutics·Marimuthu CitartanThean-Hock Tang
Oct 23, 2020·Chemical Society Reviews·Zoë Rachael GoddardMark Searcey
May 3, 2019·Pharmacology & Therapeutics·Tanweer HaiderVandana Soni
Jun 8, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Tengteng ZouYu Cai
Jan 25, 2018·Journal of the American Chemical Society·Kelsey K SakimotoPeidong Yang
Jun 7, 2018·ACS Applied Materials & Interfaces·Jun YueTeri W Odom
Dec 31, 2020·ACS Central Science·Jingtian HuTeri W Odom
Oct 14, 2019·ACS Biomaterials Science & Engineering·Thiruganesh RamasamyJong Oh Kim
May 12, 2018·The Journal of Physical Chemistry Letters·Kayla S B CulverTeri W Odom
Sep 2, 2021·Bioactive Materials·Lei WuJun Yue
Oct 9, 2021·Signal Transduction and Targeted Therapy·Wenjuan MaYunfeng Lin
Oct 10, 2021·Advanced Healthcare Materials·Zhaoyu MaHeyou Han

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis